BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19944070)

  • 1. Comparative deacetylase activity of wild type and mutants of SIRT1.
    Malik R; Kashyap A; Bansal K; Sharma P; Rayasam GV; Davis JA; Bora RS; Ray A; Saini KS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):739-43. PubMed ID: 19944070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.
    Chen L; Feng Y; Zhou Y; Zhu W; Shen X; Chen K; Jiang H; Liu D
    J Inorg Biochem; 2010 Feb; 104(2):180-5. PubMed ID: 19923004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol is not a direct activator of SIRT1 enzyme activity.
    Beher D; Wu J; Cumine S; Kim KW; Lu SC; Atangan L; Wang M
    Chem Biol Drug Des; 2009 Dec; 74(6):619-24. PubMed ID: 19843076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol.
    Lakshminarasimhan M; Curth U; Moniot S; Mosalaganti S; Raunser S; Steegborn C
    Biosci Rep; 2013 May; 33(3):. PubMed ID: 23548308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
    Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
    Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
    Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD
    J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.
    Pan M; Yuan H; Brent M; Ding EC; Marmorstein R
    J Biol Chem; 2012 Jan; 287(4):2468-76. PubMed ID: 22157016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation.
    Hou X; Rooklin D; Fang H; Zhang Y
    Sci Rep; 2016 Nov; 6():38186. PubMed ID: 27901083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
    Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L
    Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
    Tang BL
    Brain Res Bull; 2010 Mar; 81(4-5):359-61. PubMed ID: 20026255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progression of deacetylase (SIRT1)].
    Chen HZ; Zhang ZQ; Wei YS; Liu DP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):441-7. PubMed ID: 17633479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 in metabolic syndrome: where to target matters.
    Wang Y; Xu C; Liang Y; Vanhoutte PM
    Pharmacol Ther; 2012 Dec; 136(3):305-18. PubMed ID: 22939883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.
    Wu J; Zhang D; Chen L; Li J; Wang J; Ning C; Yu N; Zhao F; Chen D; Chen X; Chen K; Jiang H; Liu H; Liu D
    J Med Chem; 2013 Feb; 56(3):761-80. PubMed ID: 23316803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
    Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
    Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The controversial links among calorie restriction, SIRT1, and resveratrol.
    Hu Y; Liu J; Wang J; Liu Q
    Free Radic Biol Med; 2011 Jul; 51(2):250-6. PubMed ID: 21569839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.
    Lee SJ; Kim MM
    Life Sci; 2011 Mar; 88(11-12):465-72. PubMed ID: 21238464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.